We've partnered with Co-operative Energy and the Phone Co-op for Greenbelt 2017 to host a brand new venue and programme called The Exchange. The Exchange will focus on Enterprise for the Common Good and will provide a space to meet and discuss common issues facing cooperatives, and social and community enterprises.
Cliff Mills, of Anthony Collins Solicitors, has written a guest blog for Greenbelt 2017, which explains more about our participation and answers the question: Is it possible for something other than the pursuit of private gain to be the force that powers business? You can read the blog here.
To find out more about our involvement in Greenbelt 2017, please contact Cliff Mills.
As the tight grip of lockdown eases across the country, the Government is producing swathes of guidance as to how this will look in practice.
As the Government continues to relax social distancing requirements, many charities have found the easing of lockdown as difficult to manage as going into lockdown.
We know that from 1 August 2020, the Government will “pause” shielding.
In the first of a series of podcasts, David Alcock and Beulah Allaway from ACS talk to Chris Brown from igloo regeneration about business, social purpose and why being an ethical developer is unusual.
Catch up with all the latest charity updates in this week’s news round-up.
The Government has announced its intention to lift the shielding requirement for extremely vulnerable people. Katherine Sinclair and Libby Hubbard discuss...
The Corporate Insolvency and Governance Act 2020 has now received Royal Assent. It applies to most companies as well as Limited Liability Partnerships.
The latest development in the long history of sodium valproate was the publication of The Independent Medicines and Medical Devices Safety Review today
Failure to provide minimum pension contribution protection following a TUPE transfer can end up costing a lot more than if provision had been made.
More than 700 people were consulted about their experiences of pelvic mesh, Primodos and an epilepsy drug called Sodium Valproate.
To receive invitations to our events, as well as information and articles on legal issues and sector developments that are of interest to you, please sign up to Newsroom.